Canopy Growth (TSE:WEED – Get Free Report) had its target price dropped by investment analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research note issued on Monday,BayStreet.CA reports. The firm presently has a “sell” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential downside of 46.81% from the company’s current price.
Separately, ATB Capital lowered shares of Canopy Growth from a “sector perform” rating to an “underperform” rating and lowered their target price for the stock from C$6.00 to C$4.00 in a report on Tuesday, December 17th. Four equities research analysts have rated the stock with a sell rating and one has assigned a hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of C$5.40.
Check Out Our Latest Report on Canopy Growth
Canopy Growth Price Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- What is diluted earnings per share (Diluted EPS)?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Learn Technical Analysis Skills to Master the Stock Market
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.